Comparison of steroids and broncodilator in treatment of bronchiolitis
- Conditions
- Health Condition 1: null- bronchiolitis
- Registration Number
- CTRI/2017/11/010667
- Lead Sponsor
- Department of Pediatrics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
•All cases of bronchiolitis with a Respiratory Distress Assessment Instrument (RDAI) score of 4 to 15 [on a scale of 0 (mild) to 17 (severe)]
•An RDAI score involves assigning a numerical value to 6 separate assessments; the sum of these scores provides an RDAI score ranging from 0 to 17, with increasing scores indicating increasing respiratory distress.
1. Who received oral or inhaled corticosteroids during the preceding 2 weeks.
2. Previous diagnosis of asthma or Wheeze Associated Lower Respiratory Tract Infection.
3. Chronic disease that may affect cardiopulmonary status of the patient, such as
•Bronco pulmonary dysplasia
•Cystic fibrosis
•Congenital heart disease
•Immune deficiency.
4. Who are preterm with corrected age of less than 4 weeks at presentation
5. Congenital malformation of respiratory and cardiovascular system
6. Severe disease [clinical score > 15] requiring mechanical ventilation:
a. Saturation < 85% on room air, cyanosis, head bobbing,
b. Obtunded consciousness, and/or
c. Progressive respiratory failure.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method